Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo

Xiaocai Yan, Kara Doffek, Chaobo Yin, Michael Krein, Michael Phillips, Sonia L. Sugg, Bryon Johnson, Joel Shilyansky*

*Corresponding author for this work

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

The goal of the current study is to determine the effects of blocking phosphatidylserine (PS) on the growth of neuroblastoma in mice. PS, an anionic phospholipid restricted to the cytoplasmic surface of plasma membranes in most cells, is externalized to the surface of apoptotic cells. PS has been shown to induce immune tolerance to self-antigens. PS can also be found on the surface of live cells and in particular tumor cells. Annexin-V (AnV) is a protein that specifically binds and blocks PS. To determine the effects of blocking PS with AnV on tumor growth and immunogenicity, mice were inoculated with AGN2a, a poorly immunogenic murine neuroblastoma that expresses high level of PS on the cell surface. Survival and anti-tumor T cell response were determined. AGN2a were engineered to secrete AnV. Secreted protein effectively blocked tumor PS. 40 % of mice inoculated with AnV-expressing AGN2a cells survived free of tumor, whereas none of the mice inoculated with control cells survived (p = 0.0062). The benefits of AnV were lost when mice were depleted of T cells. The findings suggest that AnV could protect mice from tumor challenge through an immune mediated mechanism. Mice were then immunized with irradiated AnV-secreting or control cells, and challenged with wild-type AGN2a cells. AnV-secreting cell vaccine protected 80 % of mice from AGN2a challenge, while control cell vaccine prevented tumor growth in only 30 % of animals (p = 0.012). ELISPOT analysis demonstrated that AnV-secreting cell vaccine induced a greater frequency of interferon-gamma producing splenic T cells. T cells isolated from mice immunized with AnV-secreting but not control vaccine lysed AGN2a. In summary, AnV blocked PS, enhanced T cell mediated tumor immunity, and inhibited tumor growth.

Original languageEnglish (US)
Pages (from-to)1917-1927
Number of pages11
JournalCancer Immunology, Immunotherapy
Volume61
Issue number11
DOIs
StatePublished - Nov 1 2012

Keywords

  • Annexin-V
  • Neuroblastoma
  • Phosphatidylserine
  • T cell
  • Tumor
  • Tumor immunity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo'. Together they form a unique fingerprint.

  • Cite this

    Yan, X., Doffek, K., Yin, C., Krein, M., Phillips, M., Sugg, S. L., Johnson, B., & Shilyansky, J. (2012). Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo. Cancer Immunology, Immunotherapy, 61(11), 1917-1927. https://doi.org/10.1007/s00262-012-1250-4